Relevance of iPS cells in cell based screening and drug development

Drug development requires highly validated, reproducible, consistent and predictive models in order to quickly validate key targets and assess toxicity in pre-clinical assays. High quality human iPSC cells can help to that direction and Nick Clare analyses further in his presentation at ELRIG Drug Discovery 2017 how that can be achieved.